Medicine recalls
|
| |
| Canada: Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose |
| |
Health Canada announces that Pharmascience Inc. is recalling one lot of pms-Hydromorphone 2 mg tablets (lot number: 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone.
The 2 mg hydromorphone tablets are round and orange with a "2" on one side of the tablet and "pms" on the other side. The 8 mg hydromorphone tablets are round and white with an "8" on one side of the tablet and "pms" on the other side.
Hydromorphone is an opioid medication used to treat pain and opioid use disorder.
Accidentally taking too much hydromorphone (one dose of 8 mg of hydromorphone instead of one dose of 2 mg) or suddenly increasing the dose of hydromorphone could potentially lead to an overdose, which can be life-threatening even in people who have some tolerance to opioids.
Symptoms of hydromorphone overdose may include: dizziness, drowsiness, confusion, slow heartbeat, slow and difficult breathing, cold and clammy skin, seizure, coma and death.
Patients and their caregivers should be aware of the signs and symptoms of hydromorphone overdose, and should seek medical attention immediately if any of these symptoms are noted. If naloxone is available, be prepared to administer it.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/recall-one-lot-pms-hydromorphone-due-packaging-error-could-potentially-lead-overdose
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Aug 22, 2022
Issued at HKT 13:00
|
| |
